Price Chart

Historical Price Data

View and export this data back to 2013. Start Trial.
Date Open High Low Close Volume
Nov 19, 2026 2.66 2.66 2.66 2.66 0.000
Nov 18, 2026 2.66 2.66 2.66 2.66 0.000
Nov 17, 2026 2.66 2.66 2.66 2.66 0.000
Nov 16, 2026 2.66 2.66 2.66 2.66 0.000
Nov 13, 2026 2.66 2.66 2.66 2.66 0.000
Nov 12, 2026 2.66 2.66 2.66 2.66 5.000
Nov 11, 2026 2.66 2.66 2.66 2.66 0.000
Nov 10, 2026 2.66 2.66 2.66 2.66 0.000
Nov 09, 2026 2.66 2.66 2.66 2.66 0.000
Nov 06, 2026 2.66 2.66 2.66 2.66 100.00
Nov 05, 2026 2.49 2.49 2.49 2.49 65.00
Nov 04, 2026 2.49 2.49 2.49 2.49 0.000
Nov 03, 2026 2.49 2.49 2.49 2.49 0.000
Nov 02, 2026 2.49 2.49 2.49 2.49 0.000
Oct 30, 2026 2.49 2.49 2.49 2.49 0.000
Oct 29, 2026 2.49 2.49 2.49 2.49 0.000
Oct 28, 2026 2.49 2.49 2.49 2.49 0.000
Oct 27, 2026 2.49 2.49 2.49 2.49 100.00
Oct 26, 2026 3.37 3.37 3.37 3.37 0.000
Oct 23, 2026 3.37 3.37 3.37 3.37 0.000
Oct 22, 2026 3.37 3.37 3.37 3.37 0.000
Oct 21, 2026 3.37 3.37 3.37 3.37 0.000
Oct 20, 2026 3.37 3.37 3.37 3.37 0.000
Oct 19, 2026 3.37 3.37 3.37 3.37 0.000
Oct 16, 2026 3.37 3.37 3.37 3.37 0.000

Price Definition

The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).

Read full definition.

Price Range, Past 5 Years

View Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Benchmarks

View Price Benchmarks
Start Trial
Nicox SA 0.30
DBV Technologies SA 9.42
Cellectis SA 0.9838
Genfit SA 9.43
Innate Pharma SA 0.9399

Price Related Metrics

PS Ratio 2.821
PEG Ratio -0.0189
Price to Book Value 5.439
Earnings Yield -39.35%
Market Cap 504.46M
PEGY Ratio -0.0189